William Blair Brokers Cut Earnings Estimates for P3 Health Partners Inc. (NASDAQ:PIII)

P3 Health Partners Inc. (NASDAQ:PIIIFree Report) – Equities research analysts at William Blair lowered their Q1 2024 EPS estimates for P3 Health Partners in a report released on Monday, April 1st. William Blair analyst R. Daniels now anticipates that the company will earn ($0.19) per share for the quarter, down from their previous forecast of ($0.15). William Blair has a “Outperform” rating on the stock. The consensus estimate for P3 Health Partners’ current full-year earnings is ($0.54) per share. William Blair also issued estimates for P3 Health Partners’ Q2 2024 earnings at ($0.17) EPS, Q3 2024 earnings at ($0.12) EPS, Q4 2024 earnings at ($0.09) EPS, FY2024 earnings at ($0.56) EPS and FY2025 earnings at ($0.49) EPS.

Other equities research analysts have also issued reports about the stock. BTIG Research lowered shares of P3 Health Partners from a “buy” rating to a “neutral” rating in a research report on Monday. Lake Street Capital decreased their target price on P3 Health Partners from $9.00 to $4.50 and set a “buy” rating for the company in a report on Thursday, March 14th.

Check Out Our Latest Report on P3 Health Partners

P3 Health Partners Stock Performance

Shares of P3 Health Partners stock opened at $0.79 on Wednesday. The firm’s fifty day simple moving average is $1.04 and its 200-day simple moving average is $1.25. P3 Health Partners has a 12 month low of $0.66 and a 12 month high of $5.56. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.67 and a quick ratio of 0.67. The stock has a market capitalization of $247.40 million, a price-to-earnings ratio of -1.22 and a beta of 1.04.

Hedge Funds Weigh In On P3 Health Partners

Institutional investors and hedge funds have recently bought and sold shares of the stock. JPMorgan Chase & Co. boosted its stake in shares of P3 Health Partners by 18.1% during the 2nd quarter. JPMorgan Chase & Co. now owns 13,599 shares of the company’s stock valued at $51,000 after buying an additional 2,087 shares during the last quarter. Principal Financial Group Inc. increased its holdings in shares of P3 Health Partners by 13.3% during the third quarter. Principal Financial Group Inc. now owns 80,055 shares of the company’s stock valued at $118,000 after purchasing an additional 9,400 shares during the period. BNP Paribas Arbitrage SNC acquired a new position in shares of P3 Health Partners during the third quarter valued at $44,000. Forum Financial Management LP acquired a new position in shares of P3 Health Partners during the first quarter valued at $78,000. Finally, Goldman Sachs Group Inc. acquired a new position in shares of P3 Health Partners during the first quarter valued at $80,000. Hedge funds and other institutional investors own 7.75% of the company’s stock.

About P3 Health Partners

(Get Free Report)

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.

Further Reading

Earnings History and Estimates for P3 Health Partners (NASDAQ:PIII)

Receive News & Ratings for P3 Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for P3 Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.